Archive for the ‘Lyme’ Category

What We Still Don’t Understand About Tick-Borne Disease: Adam Finnegan

https://rumble.com/v7cv61c-the-sleeper-agent-adam-finnegan.html? Video Here

The Sleeper Agent – Adam Finnegan. What We Still Don’t Understand About Tick-Borne Disease

DrSherriTenpenny

Streamed on:Jul 17, 8:00 pm

Most people do not fully understand the devastation that can follow a tick bite. This illness has stolen careers, destroyed families, robbed people of their memories, and left some wondering if they will ever get their lives back. For some, a single bite is followed by years of crushing fatigue, chronic pain, neurological problems, brain fog, and the frightening realization that they are no longer the person they used to be.

Adam Finnegan knows that reality personally. After developing chronic Lyme disease in 2016, he spent seven years trying to answer one question: Why do some people never seem to recover, and why are so many still searching for answers years after the bite itself has been forgotten?

That search became The Sleeper Agent: The Rise of Lyme Disease, Chronic Illness, and the Great Imitator Antigens of Biological Warfare.

In this episode, you’ll learn why Finnegan believes the story of Lyme disease may be much bigger than a tick bite. He explains the science of immune tolerance and why some chronically ill patients may look “normal” on paper while their health continues to deteriorate. He discusses why so many people with persistent symptoms feel abandoned by medicine and why the history of military research into ticks, animal pathogens, and biological warfare led him down a path he never expected to take.

You’ll hear why Erich Traub became one of the central figures in his investigation, why Operation Paperclip matters to this story, and why he believes some of the biggest questions surrounding chronic illness have not been fully answered.

The interview introduces the investigation. The book contains more than 1,000 citations and the deeper historical record.

This episode does not ask you to accept a conclusion. It asks you to look at the evidence, consider the questions, and decide for yourself whether the accepted story explains everything.

Because if one tiny tick can change a life forever, perhaps we still do not understand the full story of what happens next.

Purchase a copy of the book at: https://amzn.to/44Lc5jD

_______________

For more:

Category:

Lyme, Ticks

Old Molecule, New Evidence: Chlorine Dioxide Shows Promise in 3 Veterinary Cases

https://imahealth.substack.com/p/old-molecule-new-evidence-chlorine?

Old Molecule, New Evidence: Chlorine Dioxide Shows Promise in Three Veterinary Cases

Three animals with limited options improved after treatment with chlorine dioxide. A new case series in the Journal of Independent Medicine documents what happened.

Independent Medical Alliance

May 27, 2026

The FDA calls chlorine dioxide “a dangerous bleach.” Millions of people drink low doses of it every day in treated tap water. And clinicians and veterinarians have been quietly using it for years to treat conditions that conventional medicine couldn’t resolve.

A new case series in the Journal of Independent Medicine puts clinical outcomes on the record for the first time in veterinary medicine.

Teresa Carr, a veterinarian with 30 years of clinical experience, and Mitchell Liester, MD, an adjoint assistant professor in the Department of Psychiatry at the University of Colorado School of Medicine, documented what happened when they used chlorine dioxide protocols on three animals that had run out of conventional options. A dog with suspected liver cancer. A cat with an infection that wouldn’t respond to antibiotics. A dog with a large, painful mammary tumor. All three improved.

“I began independently researching alternative therapies for patients with more complex conditions.” — Teresa Carr

📖 Read and Download the Full Paper

Chlorine Dioxide as an Adjunctive Treatment in Three Veterinary Cases: A Case Series (JIM Vol. 2, No. 3, 2026) — Authors: Teresa Carr and Mitchell Liester

What Chlorine Dioxide Is

Chlorine dioxide is a selective oxidant first synthesized in 1811. This is not the stuff you accidentally gulped at the swimming pool as a kid. It is a distinct molecule with a different mechanism of action: it selectively oxidizes specific amino acids in microbial proteins, disrupting their function and replication. That gives it broad-spectrum antimicrobial activity against bacteria, viruses, fungi, and parasites.

“Chlorine dioxide was synthesized over 200 years ago, but was primarily used as a water treatment agent. It also has broad spectrum antimicrobial activity against bacteria, viruses, fungi, and parasites.” — Mitchell Liester

Regulatory agencies have approved it for water treatment, food safety, and medical equipment sterilization. The antimicrobial properties are not in dispute. What’s been missing is formal clinical investigation.

The human data that does exist is promising. Studies have documented improved glucose control, reduced inflammation, enhanced wound healing, and activity against antibiotic-resistant pathogens. A case series showed complete resolution of treatment-refractory diabetic foot ulcers, with one patient achieving sustained medication-free glycemic control for three years.

The Safety Question

The FDA labeled chlorine dioxide “a dangerous bleach” during the COVID pandemic and pursued criminal enforcement against people promoting its use. Carr and Liester argue that label was based on high-dose misuse, not on the low-dose therapeutic protocols practitioners are actually using.

“The FDA during the COVID pandemic labeled chlorine dioxide a dangerous bleach. Now, this was based on very high doses being misused, not on the low doses that have been demonstrated to be safe.” — Mitchell Liester

The safety data at low doses tells a different story:

  • The EPA established a no-observed-adverse-effect level of 3 mg/kg/day for oral chlorine dioxide
  • Phase I and II clinical trials for ALS confirmed that IV sodium chlorite at doses up to 3.2 mg/kg/day was safe and well-tolerated, with no serious adverse events
  • Millions of people consume low-dose chlorine dioxide daily in municipal drinking water
  • In these three veterinary cases, no adverse effects across enema, oral, and intratumoral routes over treatment periods ranging from 10 days to 8 months

Calling this compound “a dangerous bleach” while millions drink it daily is, as the authors put it, like labeling chemotherapy a poison based solely on high-dose toxicity.

Why the Evidence Stays Thin

If the safety data is there and practitioners are already using it, why does the evidence base remain so limited?

The answer is structural. Chlorine dioxide cannot be patented. That means no pharmaceutical company has a financial incentive to fund the controlled trials that regulators require for approval. Regulators prohibit its therapeutic use because those trials don’t exist. And the prohibition makes it harder for researchers to generate the data that would justify lifting it.

“This compound is not patentable, and therefore it’s unlikely that pharmaceutical companies will want to fund further research.” — Mitchell Liester

(See top link for article and video)

________________

For more:

Category:

Lyme, Malaria, research, Treatment

The Secret History of Lyme Disease the US Government Doesn’t Want You to Know

The secret history of Lyme disease the US government doesn’t want you to know | Unreported

Jun 17, 2026 Unreported with Meagan Medick

Nearly half a million Americans are diagnosed with Lyme disease every year, and ER tick bite visits are hitting the highest levels since 2017. So why does it feel like nobody is sounding the alarm? And why is Congress now ordering a federal watchdog to dig through decades of classified Cold War military records searching for answers?

In this episode of “Unreported,” Meagan Medick sits down with author Kris Newby, who wrote “Bitten: The Secret History of Lyme Disease and Biological Weapons” and is a senior producer on the Oscar semi-finalist documentary “Under Our Skin.” Together, they examine documented evidence that the U.S. government experimented on ticks as potential Cold War bioweapons, the whistleblower testimony of the scientist who discovered Lyme disease and why a mystery organism he identified in the original ticks was quietly removed from his discovery paper.

They also dig into the Lone Star tick experiments that may have seeded the Northeast with nonnative species, the rise of meat allergies and why a new Lyme vaccine is already raising red flags. Plus: what the Cold War records investigation in Congress could uncover and who controls what gets released.

For more:

Category:

Activism, Lyme, Ticks, Transmission

Vineyard Gazette: Scientists Study Martha’s Vineyard to Get to Root of Chronic Lyme

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/34959511

Vinyard Gazette: Scientists Study Martha’s Vineyard to Get to Root of Chronic Lyme

Carl TuttleHudson, NH, United States

Jul 13, 2026

God forbid we find better antimicrobials for treating Lyme disease because that would give the public an excuse not to take the Lyme vaccine soon to be released!!!

—– Forwarded Message —–
From: CARL TUTTLE <runagain@comcast.net>
To: egenter@vineyardgazette.com <egenter@vineyardgazette.com>; bill@vineyardgazette.com <bill@vineyardgazette.com>; news@vineyardgazette.com <news@vineyardgazette.com>
Cc: linden.hu@tufts.edu <linden.hu@tufts.edu>; cseguin@partners.org <cseguin@partners.org>; jayanta.bhattacharya@nih.hhs.gov <jayanta.bhattacharya@nih.hhs.gov>; Stephanie.Haridopolos@hhs.gov <stephanie.haridopolos@hhs.gov>; kalachakra108@aol.com <kalachakra108@aol.com>; kbliegnermd@optonline.net <kbliegnermd@optonline.net>
Sent: Tuesday, June 30, 2026 at 02:26:37 PM EDT
Subject: Vinyard Gazette: Scientists Study Martha’s Vineyard to Get to Root of Chronic Lyme

Vinyard Gazette
Scientists Study Martha’s Vineyard to Get to Root of Chronic Lyme
https://vineyardgazette.com/news/2026/06/28/scientists-study-marthas-vineyard-get-root-chronic-lyme
By Ethan Genter June 28, 2026

Excerpt:
“We don’t really have any idea,” said Dr. Linden Hu, an infectious disease specialist at Tufts who is helping lead the research. “We had the same hypotheses we had 30 years ago with no clear .
“People are recruited when they have the tell-tale rash – one of the earliest signs of Lyme disease.”

Vineyard Gazette
Edgartown, MA
Attn: Ethan Genter, News Editor

Dear Ethan,
Please see the following eleven articles published in the peer-reviewed literature on dapsone combination therapy for Lyme disease and the MSIDS model. Does Dr. Hu really not know about them, or dismisses Dr. Horowitz’ results because it’s not based on a randomized trial? It is interesting that Tufts received millions of dollars of research money from the NIH and Horowitz couldn’t get a 250k grant approved for a randomized, multicenter trial. More on that found here:

Dr. Jay Bhattacharya; Fund Dr. Richard Horowitz’ R34 NIH grant on Dapsone treatment for Lyme disease
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/34365550

As for Hu’s research, it is focusing on the acute or early stage of the disease while patients who are the sickest went years or decades before obtaining a diagnosis ignoring the late-stage Lyme epidemic seen all across this nation. What academic discipline would Hu encounter if he focused on better antimicrobials???
11 Dapsone Articles on The Effective Treatment of Chronic LD & Associated Co-infections Including Bartonella: As of April 2026
Horowitz, R. Improving biomarkers of inflammation including phosphorylated tau in a patient with chronic Lyme disease/post-treatment Lyme disease syndrome using dapsone combination therapy: A case study and literature review. Journal of Alzheimer’s Disease Reports. April 27, 2026. DOI: 10.1177/25424823261445434 https://journals.sagepub.com/…/10.1177/25424823261445434
Horowitz, R.I.; Fallon, J.; Freeman, P.R. Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review. Microorganisms 2024, 12, 909. https://doi.org/10.3390/microorganisms12050909
Horowitz, R.I.; Fallon, J.; Freeman, P.R. Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections. Microorganisms 2023, 11, 2301. https://doi.org/10.3390/microorganisms11092301
Horowitz RI, Freeman PR. Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review. Antibiotics. 2022; 11(7):912. https://doi.org/10.3390/antibiotics11070912
https://www.mdpi.com/2079-6382/11/7/912/htm
Horowitz, R.I.; Freeman, P.R. Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review. Antibiotics 2020, 9, 725. https://doi.org/10.3390/antibiotics9110725
Horowitz, R.I., Murali, K., Gaur, G. et al. Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi. BMC Res Notes 13, 455 (2020). https://doi.org/10.1186/s13104-020-05298-6
https://bmcresnotes.biomedcentral.com/…/s13104-020
Horowitz, R.I.; Freeman, P.R. Precision Medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1. International Journal of General Medicine 2019:12 101–119
https://www.dovepress.com/precision-medicine
https://www.ncbi.nlm.nih.gov/pubmed/30863136
https://www.ncbi.nlm.nih.gov/pubmed/30863136
Horowitz, R.I.; Freeman, P.R. Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2. Healthcare 2018, 6, 129.
https://www.ncbi.nlm.nih.gov/pubmed/30400667
Horowitz RI, Freeman PR (2016) Are Mycobacterium Drugs Effective for Treatment Resistant Lyme Disease, Tick-Borne Co-Infections, and Autoimmune Disease?. JSM Arthritis 1(2): 1008.
Horowitz RI, Freeman PR (2016) The Use of Dapsone as a Novel “Persister” Drug in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome. J Clin Exp Dermatol Res 7: 345. doi:10.4172/2155-9554.1000345
Tardo AC, McDaniel CE and Embers ME (2023). Superior efficacy of combination antibiotic therapy versus monotherapy in a mouse model of Lyme disease. Front. Microbiol. 14:1293300. doi: 10.3389/fmicb.2023.1293300
https://www.frontiersin.org/…/fmicb.2023.1293300/full
Dapsone documentary 2024:
https://drtalks.com/…/discover-healing-18-dapsone…/
Dapsone documentary 2025:
https://drtalks.com/…/dapsone-documentary-9-stories-of
Dr. H Podcast with Dr Alain Mass and Dr Charlie Bizilj on The Success of Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease. May 21, 2025
https://us06web.zoom.us/…/TSVaYe6azIti
Passcode: &0yqten0
Dr. Horowitz has a new book and website, which has the 2000+ scientific references in Ending Chronic Illness listed on the site for review.
https://cangetbetter.com/

Respectfully Submitted,
Carl Tuttle
Independent Researcher
Hudson, NH
Cc:
-Dr. Linden Hu, Professor of Immunology at Tufts Medical School
-Claire Seguin, DNP, President and Chief Operating Officer of Martha’s Vineyard Hospital
-Bill Eville, Editor Vinyard Gazette
-Stephanie E. Haridopolos, MD, DABFM Principal Deputy Assistant Secretary for Health
-Jay Bhattacharya, Director of the National Institutes of Health
-Dr. Richard Horowitz, MD Board certified internist in private practice in Hyde Park, New York
-Dr. Kenneth B. Liegner Board Certified Internist with additional training in Pathology and Critical Care Medicine, practicing in Pawling, New York.
Paralyzed by Lyme, they were helped with combo treatments (please read!!!)
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/31772769

Sign this petition

Category:

Activism, Lyme, research, Treatment, vaccines

Why You Still Feel Sick After Standard Lyme Treatment

Why You Still Feel Sick After Standard Lyme Treatment

Dr. Jaquel Patterson

June 10, 2026

Lyme disease rarely travels alone, and unaddressed co-infections like Bartonella, Babesia, Ehrlichia, Anaplasma, Mycoplasma, and Rickettsia are some of the most common reasons chronic Lyme patients don’t recover. In this video, I walk through how each co-infection is distinct, why standard Lyme antibiotics don’t cover them, and what a truly comprehensive testing and treatment approach should look like. Learn more: https://www.fairfieldfamilyhealth.com

CHAPTERS

00:00 Why Lyme Treatment Often Isn’t Enough

01:32 What Tick Borne Co-Infections Actually Are

02:54 Bartonella, Babesia, and Why They Get Missed

06:55 Why Standard Lyme Testing Fails to Catch Co-Infections

08:46 The Clinical Patterns That Point to Hidden Infections

09:55 What Comprehensive Tick Borne Testing Looks Like

11:37 Treatment Protocols for Each Co-Infection

14:29 Final Takeaways for Chronic Lyme Patients

________________

**Comment**

And this, right here, is why many patients are not better and never get better. Further, testing absolutely sucks. ALL of it. Pathogens working together create a severe clinical picture. Many of these pathogens require completely different medications. Mainstream doctors are clueless on all of this and have furthered an antiquated, unscientific case definition and treatment protocol for over 40 years.

It is far, far more complex than most doctors are aware. They spend very little time studying this in med school and what they do study is completely wrong.

For more:

Category:

Activism, Lyme, Testing, Treatment